Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial
======================================================================================================================================================================================================

* Axel Stenmark Tullberg
* Martin Sjöström
* Lena Tran
* Emma Niméus
* Fredrika Killander
* Anikó Kovács
* Dan Lundstedt
* Erik Holmberg
* Per Karlsson